Schneeweiss S

References (3)

Title : Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study - Kim_2015_Ann.Rheum.Dis_74_1968
Author(s) : Kim SC , Schneeweiss S , Glynn RJ , Doherty M , Goldfine AB , Solomon DH
Ref : Ann Rheum Dis , 74 :1968 , 2015
Abstract : Kim_2015_Ann.Rheum.Dis_74_1968
ESTHER : Kim_2015_Ann.Rheum.Dis_74_1968
PubMedSearch : Kim_2015_Ann.Rheum.Dis_74_1968
PubMedID: 24919467

Title : Psychotropic medication use for behavioral symptoms of dementia - Wang_2006_Curr.Neurol.Neurosci.Rep_6_490
Author(s) : Wang PS , Brookhart MA , Setoguchi S , Patrick AR , Schneeweiss S
Ref : Curr Neurol Neurosci Rep , 6 :490 , 2006
Abstract : Wang_2006_Curr.Neurol.Neurosci.Rep_6_490
ESTHER : Wang_2006_Curr.Neurol.Neurosci.Rep_6_490
PubMedSearch : Wang_2006_Curr.Neurol.Neurosci.Rep_6_490
PubMedID: 17074284

Title : Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients - Thacker_2006_Drug.Saf_29_1077
Author(s) : Thacker EL , Schneeweiss S
Ref : Drug Safety , 29 :1077 , 2006
Abstract : Thacker_2006_Drug.Saf_29_1077
ESTHER : Thacker_2006_Drug.Saf_29_1077
PubMedSearch : Thacker_2006_Drug.Saf_29_1077
PubMedID: 17061913